MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 203 filers reported holding MYRIAD GENETICS INC in Q2 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $674 | -5.2% | 42 | -14.3% | 0.00% | – |
Q4 2022 | $711 | -82.2% | 49 | -67.3% | 0.00% | – |
Q1 2022 | $4,000 | -86.7% | 150 | -85.0% | 0.00% | – |
Q1 2021 | $30,000 | +100.0% | 1,000 | -14.0% | 0.00% | – |
Q3 2020 | $15,000 | +36.4% | 1,163 | +20.8% | 0.00% | – |
Q2 2020 | $11,000 | +120.0% | 963 | +173.6% | 0.00% | – |
Q1 2020 | $5,000 | -72.2% | 352 | -45.4% | 0.00% | – |
Q4 2019 | $18,000 | +80.0% | 645 | +83.2% | 0.00% | – |
Q3 2019 | $10,000 | -9.1% | 352 | -11.3% | 0.00% | – |
Q2 2019 | $11,000 | -15.4% | 397 | 0.0% | 0.00% | – |
Q1 2019 | $13,000 | +18.2% | 397 | +5.6% | 0.00% | – |
Q4 2018 | $11,000 | -31.2% | 376 | +6.8% | 0.00% | – |
Q3 2018 | $16,000 | +23.1% | 352 | 0.0% | 0.00% | – |
Q2 2018 | $13,000 | +30.0% | 352 | 0.0% | 0.00% | – |
Q1 2018 | $10,000 | -16.7% | 352 | 0.0% | 0.00% | – |
Q4 2017 | $12,000 | -33.3% | 352 | -29.3% | 0.00% | – |
Q3 2017 | $18,000 | +38.5% | 498 | 0.0% | 0.00% | – |
Q2 2017 | $13,000 | +30.0% | 498 | 0.0% | 0.00% | – |
Q1 2017 | $10,000 | +25.0% | 498 | -4.2% | 0.00% | – |
Q4 2016 | $8,000 | -63.6% | 520 | -28.6% | 0.00% | – |
Q2 2016 | $22,000 | -21.4% | 728 | 0.0% | 0.00% | – |
Q1 2016 | $28,000 | -34.9% | 728 | -26.2% | 0.00% | -100.0% |
Q4 2015 | $43,000 | +10.3% | 986 | -4.9% | 0.00% | 0.0% |
Q3 2015 | $39,000 | +11.4% | 1,037 | +0.7% | 0.00% | 0.0% |
Q2 2015 | $35,000 | -10.3% | 1,030 | -5.3% | 0.00% | 0.0% |
Q1 2015 | $39,000 | +8.3% | 1,088 | +2.6% | 0.00% | 0.0% |
Q4 2014 | $36,000 | +24.1% | 1,060 | +39.8% | 0.00% | 0.0% |
Q3 2014 | $29,000 | +31.8% | 758 | +37.1% | 0.00% | 0.0% |
Q2 2014 | $22,000 | +15.8% | 553 | 0.0% | 0.00% | 0.0% |
Q1 2014 | $19,000 | +35.7% | 553 | -18.8% | 0.00% | 0.0% |
Q4 2013 | $14,000 | -76.3% | 681 | -72.6% | 0.00% | -66.7% |
Q3 2013 | $59,000 | -11.9% | 2,485 | 0.0% | 0.00% | -25.0% |
Q2 2013 | $67,000 | – | 2,485 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 2,750,000 | $75,900,000 | 2.61% |
PFM Health Sciences, LP | 2,025,681 | $55,909,000 | 1.90% |
Tieton Capital Management, LLC | 118,456 | $3,269,000 | 1.83% |
Altium Capital Management LP | 190,000 | $5,244,000 | 1.45% |
DISCIPLINED GROWTH INVESTORS INC /MN | 1,846,490 | $50,963,000 | 1.03% |
EARNEST PARTNERS LLC | 6,316,365 | $174,332,000 | 1.01% |
Glenview Capital Management | 1,679,747 | $46,361,000 | 0.99% |
Zebra Capital Management LLC | 14,209 | $392,000 | 0.63% |
AIMZ Investment Advisors, LLC | 44,185 | $1,220,000 | 0.48% |
Phocas Financial Corp. | 132,101 | $3,646,000 | 0.46% |